Market Place
Sourcing Support
Tonix Pharma Unveils Immuno-Oncology Progress At AACR 2026
23 Apr 2026 //
GLOBENEWSWIRE
Tonix Pharma Reveals 2025 Financials And Operational Achievements
12 Mar 2026 //
GLOBENEWSWIRE
Tonix Pharma Publishes Clinical Pharmacokinetic Studies of TONMYA
05 Mar 2026 //
GLOBENEWSWIRE
Tonix Pharma Announces Uplisting from Nasdaq Capital Market
03 Mar 2026 //
GLOBENEWSWIRE
Tonix Pharma To Join 2 Investor Conferences In March
25 Feb 2026 //
GLOBENEWSWIRE
Tonix Pharma Prices $20M Registered Direct Offering
29 Dec 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Appoints Irina Ishak As General Counsel
09 Dec 2025 //
GLOBENEWSWIRE
Tonix Pharma Launches Tonmya for Fibromyalgia in US
17 Nov 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Presentation At Bio-Europe 2025
28 Oct 2025 //
GLOBENEWSWIRE
Tonix Pharma Appoints Ganesh Kamath As Head Of Market Access
30 Sep 2025 //
GLOBENEWSWIRE
Segal Trial Contribute to FDA Approval of Tonmya for Fibromyalgia
10 Sep 2025 //
PHARMAWEB
Tonix Pharma Reveals Tonmya™ Clinical Data for Fibromyalgia
08 Sep 2025 //
GLOBENEWSWIRE
FDA Nods Tonix Pharma`s Drug to Manage Pain in Chronic Condition
18 Aug 2025 //
PRESS RELEASE
Tonix Pharmaceuticals Q2 2025 Financial Results and Highlights
11 Aug 2025 //
GLOBENEWSWIRE
Tonix Pharma Publishes Phase 3 Trial Results for Fibromyalgia
09 Jul 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Presents TNX-102 SL Fibromyalgia Data at EU
16 Jun 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Appoints James “Jim” Hunter to Board
13 Jun 2025 //
GLOBENEWSWIRE
Tonix Pharma to Present at A.G.P. Annual Healthcare Showcase
22 May 2025 //
GLOBENEWSWIRE
Tonix Doses First Patient In Ph2 Oasis Study Of TNX-102 SL
21 May 2025 //
GLOBENEWSWIRE
Tonix Appoints Joseph as GC & Executive VP of Operations
14 May 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Reports Q1 2025 Financial Results
12 May 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Presents Preclinical Data at AACR 2025
29 Apr 2025 //
GLOBENEWSWIRE
Tonix culls cocaine intoxication trial amid enrollment woes
28 Apr 2025 //
FIERCE BIOTECH
Tonix Pharma Present at World Vaccine Congress Washington 2025
16 Apr 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Data on TNX-102 SL for Fibromyalgia at AAPM
07 Apr 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at 2025 Jones Trading Conference
02 Apr 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at AAPM 2025 Annual Meeting
27 Mar 2025 //
GLOBENEWSWIRE
Tonix Pharma: FDA Skips Advisory Panel For Tnx-102 SL In Fibromyalgia
24 Mar 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Reports Q4 and Full Year 2024 Results
18 Mar 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals presents at BIO-Europe Spring 2025
13 Mar 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at 2025 Virtual Investor Summit
05 Mar 2025 //
GLOBENEWSWIRE
Tonix Presents TNX-102 SL Data At Fibromyalgia Congress
04 Mar 2025 //
GLOBENEWSWIRE
Tonix Announces Preliminary 2024 Results & Year-End Cash
07 Feb 2025 //
GLOBENEWSWIRE
Tonix Pharma to Participate in 2025 BIO CEO & Investor Conference
05 Feb 2025 //
GLOBENEWSWIRE
Tonix Pharma Promotes Siobhan Fogarty to Chief Technical Officer
04 Feb 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split
03 Feb 2025 //
GLOBENEWSWIRE
Tonix Pharma Appoints Gary Ainsworth As VP Of Market Access
08 Jan 2025 //
GLOBENEWSWIRE
Tonix To Present At Two Investor Conferences This January
07 Jan 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces PDUFA Goal Date for Fibromyalgia
23 Dec 2024 //
GLOBENEWSWIRE
Tonix Announces FDA Acceptance of TNX-102 SL NDA for Fibromyalgia
17 Dec 2024 //
GLOBENEWSWIRE
Tonix Pharma Expands Leadership Team with Two Strategic Hires
03 Dec 2024 //
GLOBENEWSWIRE
Tonix Pharma to Participate in NobleCon20 Investor Conference
26 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharma Presents TNX-102 SL Data for Fibromyalgia at ACR 2024
18 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharma to Present at Winter 2024 Investor Summit Virtual
18 Nov 2024 //
GLOBENEWSWIRE
Tonix Targets Rapid Migraine Relief With Non-Oral Treatments
14 Nov 2024 //
ACCESSWIRE
Tonix Pharma Announces Poster at ACR Convergence Annual Meeting
13 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharma Reports Q3 2024 Financial Results & Operational
12 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at BIO-Europe® 2024
29 Oct 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference
25 Oct 2024 //
GLOBENEWSWIRE
Tonix Receives Contract Payment For Antiviral Development
17 Oct 2024 //
GLOBENEWSWIRE
Tonix Submits TNX-102 SL NDA For Fibromyalgia To The FDA
16 Oct 2024 //
GLOBENEWSWIRE
Two Companies Near FDA Decisions On Non-Addictive Painkillers
01 Oct 2024 //
ACCESSWIRE
Tonix Pharmaceuticals Announces Patent For Zembrace SymTouch
27 Sep 2024 //
GLOBENEWSWIRE
Tonix Announces TNX-102 SL Presentations At PDDS 2024
23 Sep 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Issuance Of U.S. Patent
19 Sep 2024 //
GLOBENEWSWIRE
Tonix Appoints Thomas Englese As EVP Commercial Operations
10 Sep 2024 //
GLOBENEWSWIRE
Tonix Launches Campaign On Gastroparesis Impact On Migraine Meds
06 Sep 2024 //
GLOBENEWSWIRE
Tonix Presents TNX-102 SL Data for Stress Reduction and Wound Healing at MHSRS
29 Aug 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Presented TNX-102 SL Data At MHSRS 2024
28 Aug 2024 //
GLOBENEWSWIRE
Tonix To Present At 2024 Military Health Research Symposium
21 Aug 2024 //
GLOBENEWSWIRE
